Atlas Trials

A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES)

Clinical trial NCT07717840 · RECRUITING

Trial details

NCT number
NCT07717840
Sponsor
AstraZeneca
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
RSV Respiratory Syncytial Virus
Start date
2026-07-08
Primary completion
2026-10-15
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.